337 related articles for article (PubMed ID: 8759987)
1. Beneficial effects of corticosteroids on ocular myasthenia gravis.
Kupersmith MJ; Moster M; Bhuiyan S; Warren F; Weinberg H
Arch Neurol; 1996 Aug; 53(8):802-4. PubMed ID: 8759987
[TBL] [Abstract][Full Text] [Related]
2. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
3. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
Kupersmith MJ; Ying G
Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
[TBL] [Abstract][Full Text] [Related]
4. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
[TBL] [Abstract][Full Text] [Related]
5. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
Kupersmith MJ
J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
Brunner NG; Berger CL; Namba T; Grob D
Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590
[TBL] [Abstract][Full Text] [Related]
7. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
[TBL] [Abstract][Full Text] [Related]
8. Long-term prednisone followed by thymectomy in myasthenia gravis.
Mann JD; Johns TR; Campa JF; Muller WH
Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of Ocular Myasthenia Gravis: Retrospective Multicenter Analysis.
Nagia L; Lemos J; Abusamra K; Cornblath WT; Eggenberger ER
Ophthalmology; 2015 Jul; 122(7):1517-21. PubMed ID: 25892018
[TBL] [Abstract][Full Text] [Related]
10. Medical and surgical treatment for ocular myasthenia.
Benatar M; Kaminski H
Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Low-to-Moderate Dose Oral Corticosteroid Treatment in Ocular Myasthenia Gravis.
Lee YG; Kim US
J Pediatr Ophthalmol Strabismus; 2018 Sep; 55(5):339-342. PubMed ID: 30074608
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis.
Mee J; Paine M; Byrne E; King J; Reardon K; O'Day J
J Neuroophthalmol; 2003 Dec; 23(4):251-5. PubMed ID: 14663303
[TBL] [Abstract][Full Text] [Related]
13. [Ocular myasthenia: clinical course and strategies for treatment].
Marzo ME; Pérez López-Fraile I; Capablo JL; Ara JR; Usón M
Rev Neurol; 1998 Mar; 26(151):398-400. PubMed ID: 9585951
[TBL] [Abstract][Full Text] [Related]
14. Randomized Trial of Thymectomy in Myasthenia Gravis.
Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
[TBL] [Abstract][Full Text] [Related]
15. Ocular myasthenia gravis - How effective is low dose prednisone long term?
Verma R; Wolfe GI; Kupersmith MJ
J Neurol Sci; 2021 Jan; 420():117274. PubMed ID: 33360170
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical manifestations between patients with ocular myasthenia gravis and generalized myasthenia gravis.
Roh HS; Lee SY; Yoon JS
Korean J Ophthalmol; 2011 Feb; 25(1):1-7. PubMed ID: 21350687
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options in ocular myasthenia gravis.
Evoli A; Batocchi AP; Minisci C; Di Schino C; Tonali P
Neuromuscul Disord; 2001 Mar; 11(2):208-16. PubMed ID: 11257479
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
Pasnoor M; He J; Herbelin L; Burns TM; Nations S; Bril V; Wang AK; Elsheikh BH; Kissel JT; Saperstein D; Shaibani JA; Jackson C; Swenson A; Howard JF; Goyal N; David W; Wicklund M; Pulley M; Becker M; Mozaffar T; Benatar M; Pazcuzzi R; Simpson E; Rosenfeld J; Dimachkie MM; Statland JM; Barohn RJ;
Neurology; 2016 Jul; 87(1):57-64. PubMed ID: 27306628
[TBL] [Abstract][Full Text] [Related]
20. The ocular signs and symptoms of myasthenia gravis.
Oosterhuis HJ
Doc Ophthalmol; 1982 Jan; 52(3-4):363-78. PubMed ID: 7067604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
